SRC
PLXP

Shufro Rose & Co’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Shufro Rose & Co’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-82,100
Closed -$53K – 358
2022
Q3 		$53K Buy
82,100
+25,300
+45% +$37.3K 0.01% 319
2022
Q2 		$138K Buy
56,800
+23,300
+70% +$64.7K 0.01% 283
2022
Q1 		$135K Buy
+33,500
New +$184K 0.01% 301

Other funds holding PLXP

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
SGCA
Steel Grove Capital Advisors Memphis, Tennessee $949M AUM 23.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Shufro Rose & Co's PLXP Position: Q4 2022 in Review

Shufro Rose & Co sold out of PLx Pharma Inc. Common Stock (PLXP) in Q4 2022, closing a stake of 82,100 shares — an estimated $53K sold.

Shufro Rose & Co first reported a position in PLXP in Q1 2022 and held it in 3 quarters. The position peaked at $138K in Q2 2022. 41 funds tracked by Wall St. Rank hold PLXP as of Q4 2022.

  • Shufro Rose & Co reported no remaining PLx Pharma Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Shufro Rose & Co sold 82,100 PLx Pharma Inc. Common Stock shares in Q4 2022, an estimated $53K.
  • Shufro Rose & Co first reported a position in PLx Pharma Inc. Common Stock in Q1 2022 and held it in 3 quarters.
  • Shufro Rose & Co's PLx Pharma Inc. Common Stock position peaked at $138K in Q2 2022.
  • 41 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q4 2022.

Based on Shufro Rose & Co's 13F filing for Q4 2022, filed 25 Jan 2023.